Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NakanishiFRA:6SN +0.64%92 5-Year Yield-on-Cost % is 3.77 as of Jul. 31, 2026, which is 33% above its 10-year median of 2.83. GuruFocus rates FRA:6SN with a GF Score™ of 92/100 and a GF Value™ of €17.38. The stock has 8 warning signs investors should review. Among 319 Medical Devices & Instruments companies, Nakanishi ranks better than 63.64% on this metric.
Nakanishi's yield on cost for the quarter that ended in Dec. 2025 was 3.77.
The historical rank and industry rank for Nakanishi's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:6SN'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.93 Med: 2.83 Max: 5.38
Current: 3.77
During the past 13 years, Nakanishi's highest Yield on Cost was 5.38. The lowest was 1.93. And the median was 2.83.
FRA:6SN's 5-Year Yield-on-Cost % is ranked better than 63.64% of 319
companies
in the Medical Devices & Instruments industry
Industry Median: 2.45
vs FRA:6SN: 3.77
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Nakanishi 5-Year Yield-on-Cost % Related Terms
FRA:6SN vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Nakanishi's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nakanishi 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nakanishi's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Nakanishi's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Nakanishi is calculated as
Nakanishi (FRA:6SN) has a 5-Year Yield-on-Cost % of 3.77 as of Jul. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nakanishi and its competitors. This is 33% above median its historical median of 2.83. Over the past decade, Nakanishi's 5-Year Yield-on-Cost % has ranged from 1.93 to 5.38. According to the industry distribution chart, Nakanishi ranks #116 out of 319 companies in the Medical Devices & Instruments industry, placing it in the top 36.4%.
Is Nakanishi's 5-Year Yield-on-Cost % too high?
Nakanishi's current 5-Year Yield-on-Cost % of 3.77 is 33% above median its 10-year median of 2.83. Over the past 10 years, this metric has ranged from a low of 1.93 to a high of 5.38. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.45. Nakanishi's value of 3.77 is 53.9% above this industry median. Based on the distribution chart, Nakanishi ranks #116 out of 319 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nakanishi has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Nakanishi's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nakanishi ranks #116 out of 319 companies for 5-Year Yield-on-Cost %. This puts Nakanishi in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.45. Nakanishi's value of 3.77 is 53.9% above this benchmark. Historically, Nakanishi's own 5-Year Yield-on-Cost % has ranged from 1.93 to 5.38 over the past decade. While the company's 10-year median is 2.83 vs. the industry median of 2.45, Nakanishi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.45, based on 319 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nakanishi's current 5-Year Yield-on-Cost % of 3.77 is 53.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nakanishi and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakanishi's current 5-Year Yield-on-Cost % is 3.77, which is 33% above median its own 10-year median of 2.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakanishi stock overvalued right now?
Nakanishi (FRA:6SN) has a current 5-Year Yield-on-Cost % of 3.77. The stock's GF Value™ is €17.38, compared to a current price of €15.80 — trading 9.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.77, which is 33% above median its 10-year median of 2.83 and 53.9% above the Medical Devices & Instruments industry median of 2.45. Nakanishi's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Nakanishi (FRA:6SN), the current 5-Year Yield-on-Cost % is 3.77 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nakanishi (FRA:6SN) Overvalued in 2026?
Based on GuruFocus' analysis, Nakanishi stock appears to be undervalued.
The current stock price of €15.80 is trading 9.1% below its estimated GF Value™ of €17.38.
Key valuation signals for FRA:6SN:
5-Year Yield-on-Cost %: 3.77 (33% above median its 10-year median of 2.83)
GF Value™: €17.38 vs. price of €15.80 (9.1% below fair value)
Industry Position: 53.9% above the Medical Devices & Instruments median (#116 of 319)
No single metric tells the full story. See the FRA:6SN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nakanishi Inc manufactures high-speed rotary cutting technology for the dental industry and the medical industry more broadly. The company distributes its products to countries internationally, earning its key revenue overseas. The company operates via three business segments. The dental product segment manufactures and sells handpieces for dental treatment, mechanical micro motors and handpieces as well as handpieces for surgeries. The surgical business segment manufactures and sells grinders for manual works and spindles for machinery attachment. The Machinery business segment provides inspection and repair services for its dental and medical equipment and general industrial cutting and grinding equipment.
92GF Score
Get the complete analysis for FRA:6SN
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:6SN has been successfully added to your 
